Innate immune recognition of Yersinia pseudotuberculosis type III secretion by Auerbuch, Victoria et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Infectious Diseases and Immunology 
Publications Infectious Diseases and Immunology 
2009-12-04 
Innate immune recognition of Yersinia pseudotuberculosis type III 
secretion 
Victoria Auerbuch 
University of California, Santa Cruz 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/infdis_pp 
 Part of the Bacterial Infections and Mycoses Commons, Immunity Commons, Immunology of 
Infectious Disease Commons, Infectious Disease Commons, and the Pathogenic Microbiology Commons 
Repository Citation 
Auerbuch V, Golenbock DT, Isberg RR. (2009). Innate immune recognition of Yersinia pseudotuberculosis 
type III secretion. Infectious Diseases and Immunology Publications. https://doi.org/10.1371/
journal.ppat.1000686. Retrieved from https://escholarship.umassmed.edu/infdis_pp/390 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Infectious Diseases 
and Immunology Publications by an authorized administrator of eScholarship@UMMS. For more information, 
please contact Lisa.Palmer@umassmed.edu. 
Innate Immune Recognition of Yersinia
pseudotuberculosis Type III Secretion
Victoria Auerbuch1¤*, Douglas T. Golenbock2, Ralph R. Isberg1,3
1Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, 2Department of Infectious
Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America, 3Howard Hughes Medical Institute, Tufts
University School of Medicine, Boston, Massachusetts, United States of America
Abstract
Specialized protein translocation systems are used by many bacterial pathogens to deliver effector proteins into host cells
that interfere with normal cellular functions. How the host immune system recognizes and responds to this intrusive event
is not understood. To address these questions, we determined the mammalian cellular response to the virulence-associated
type III secretion system (T3SS) of the human pathogen Yersinia pseudotuberculosis. We found that macrophages devoid of
Toll-like receptor (TLR) signaling regulate expression of 266 genes following recognition of the Y. pseudotuberculosis T3SS.
This analysis revealed two temporally distinct responses that could be separated into activation of NFkB- and type I IFN-
regulated genes. Extracellular bacteria were capable of triggering these signaling events, as inhibition of bacterial uptake
had no effect on the ensuing innate immune response. The cytosolic peptidoglycan sensors Nod1 and Nod2 and the
inflammasome component caspase-1 were not involved in NFkB activation following recognition of the Y.
pseudotuberculosis T3SS. However, caspase-1 was required for secretion of the inflammatory cytokine IL-1b in response
to T3SS-positive Y. pseudotuberculosis. In order to characterize the bacterial requirements for induction of this novel TLR-,
Nod1/2-, and caspase-1-independent response, we used Y. pseudotuberculosis strains lacking specific components of the
T3SS. Formation of a functional T3SS pore was required, as bacteria expressing a secretion needle, but lacking the pore-
forming proteins YopB or YopD, did not trigger these signaling events. However, nonspecific membrane disruption could
not recapitulate the NFkB signaling triggered by Y. pseudotuberculosis expressing a functional T3SS pore. Although host cell
recognition of the T3SS did not require known translocated substrates, the ensuing response could be modulated by
effectors such as YopJ and YopT, as YopT amplified the response, while YopJ dampened it. Collectively, these data suggest
that combined recognition of the T3SS pore and YopBD-mediated delivery of immune activating ligands into the host
cytosol informs the host cell of pathogenic challenge. This leads to a unique, multifactorial response distinct from the
canonical immune response to a bacterium lacking a T3SS.
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Introduction
The ability to detect pathogens while maintaining beneficial
commensal bacteria is important for the health of animal hosts [1].
In order to defend itself against potentially injurious intruders, the
host must recognize and respond to previously unencountered
microbes. This is achieved in part by recognition of molecules
unique to microbes but common among subgroups of bacteria,
viruses, or fungi [2,3]. Detection is accomplished partially by a
group of 13 mammalian surface-associated proteins called Toll-
like receptors (TLRs) which induce an immune response upon
recognition of microbial molecules such as lipopolysaccharide and
flagellin. Beneficial commensal bacteria contain at least some TLR
ligands [1], yet aberrant TLR stimulation by commensals may
cause intestinal inflammation [4]. Therefore, mechanisms must be
in place to allow the host to distinguish between pathogenic and
commensal bacteria. Compartmentalization of TLRs facilitates
this process. For example, TLR5, which recognizes flagellin, is
only expressed on the basolateral side of intestinal epithelial cells,
from which commensal bacteria are normally absent [5]. In
contrast, pathogens possess virulence factors that allow them to
penetrate into deeper tissues sites where receptors such as TLR5
can access them [1].
In addition to TLRs, there are innate immune sensors residing
in the cytosol of mammalian cells that allow recognition of
microbial molecules at this site or damage caused by pathogenic
bacteria. One example is activation of the innate immune sensor
Nod1 by the presence of bacterially-derived peptidoglycan [6]. For
instance, Nod1 activation is triggered by the pathogen Shigella
flexneri, which is thought to shed peptidoglycan during its residence
in the host cytosol [7]. In addition, Helicobacter pylori may introduce
peptidoglycan into host cells in a process dependent on a
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specialized secretion system, activating Nod1 [8]. Both of these
microbial strategies, gaining entry into the host cytosol and
utilizing a specialized secretion system, are thought to be more
common among pathogens than commensals.
One such specialized secretion system found in a number of
pathogenic bacteria is the type III secretion system (T3SS), which
forms small pores in target host cells and delivers bacterial proteins
into the host cytosol [9]. A common result of this ‘‘injection’’ is
perturbation of normal host processes, to the benefit of the
pathogen. One human pathogen that requires a T3SS for
virulence is Yersinia pseudotuberculosis, which causes inflammation
of the gastrointestinal tract exemplified by symptoms such as fever
and swelling of gastric tissues and lymph nodes [10]. In healthy
individuals, enteropathogenic yersiniosis is usually a self-limiting
disease. However, in immunocompromised patients, the case
fatality rate approaches 50% as a result of bacterial dissemination
[11].
The Y. pseudotuberculosis T3SS is encoded on a virulence plasmid
that is also found in the closely related human pathogens Y.
enterocolitica and Y. pestis [12]. The Yersinia T3SS is composed of
three protein subgroups: those that make up the injectisome,
translocator Yops (Yersinia outer membrane proteins), and
effector Yops. The injectisome is a needle-like structure that is
evolutionarily related to the flagellar apparatus and has a central
pore of about 20 A˚ [13,14]. This needle apparatus is all that is
required for secretion of the effector Yops, but is not sufficient for
their translocation across the target cell plasma membrane.
Targeting of effector Yops into the host cell cytosol requires the
translocator proteins YopB, YopD, and LcrV, which are secreted
through the T3SS apparatus and act to form channels in host cell
membranes [15]. LcrV can be found associated with the tip of the
needle apparatus [16] where it is thought to form a scaffold for the
pore-forming proteins YopBD. T3SS effector Yops presumably
travel through the type III needle and then through the pore made
by YopBD in the host cell membrane. When the entire T3SS is
functional, Yersinia translocate a group of five to six effector
proteins into the host cytosol that interfere with target cell
functions [17]. YopE, YopT, YopH, and YopO/YpkA target the
host actin cytoskeleton, inhibiting phagocytosis and allowing the
bacteria to remain largely extracellular. YopJ/YopP inhibits
several inflammatory signaling pathways and influences the
viability of a subset of host cells [18–20], while the function of
YopM remains unknown [21].
The Yersinia T3SS pore, which forms during translocation of
effector Yops, was recently suggested to trigger processing of the
cytokines IL-1b and IL-18 in macrophages by the protease
caspase-1 [22,23]. Maturation of these cytokines has been linked
to activation of a cytosolic innate immune complex called an
inflammasome [24]. This type of complex is involved in detection
of pore formation caused by a number of bacterial toxins [25–27].
Because other pathogens expressing specialized secretion systems,
such as H. pylori, induce cytosolic innate immune sensors distinct
from those found associated with inflammasomes [8,28], we
hypothesized that other host pathways may also be involved in
recognizing the Y. pseudotuberculosis T3SS. Intriguingly, Y. pseudo-
tuberculosis was previously reported to induce production of the
chemokine IL-8 during infection of HeLa cells and this was
dependent on expression of the Y. pseudotuberculosis T3SS [29].
Therefore, we tested the ability of several mammalian cell types to
distinguish between Y. pseudotuberculosis expressing or lacking a
functional T3SS. We show here that T3SS-competent Y.
pseudotuberculosis triggers a TLR-independent transcriptional re-
sponse that includes NFkB activation as well as induction of type I
IFN-regulated genes, which are not known to be downstream of
inflammasome activation. Furthermore, the NFkB pathway
activated by the T3SS was independent of caspase-1-inflamma-
some activity. Recognition of T3SS-positive Y. pseudotuberculosis
required bacterial expression of YopBD, but did not require any of
the known effector Yops. Our results suggest that virulent Yersinia
activate multiple cytosolic immune surveillance pathways as a
consequence of utilizing a specialized secretion system.
Results
Macrophages produce TNF-a in response to extracellular
Y. pseudotuberculosis expressing a functional T3SS
independently of TLRs
To determine whether cytosolic innate immune sensors
contribute to detection of Yersinia, an infection model of
mammalian cells lacking TLR signaling was established. TLR
activation generates strong innate immune responses, many of
which overlap with those generated by cytosolic innate immune
sensors [30]. In addition, Yersinia contain many TLR ligands. To
circumvent this, we used bone marrow-derived macrophages
(BMDMs) from mice that lack the two main TLR adaptor
proteins, MyD88 and Trif, and hence lack TLR signaling
(MyD882/2/Trif2/2) [31]. The macrophage is a major in vivo
target of Yersinia type III secretion [32], making it a good candidate
for our experiments.
We initially examined the production of the inflammatory
cytokine TNF-a because it is produced downstream of several
cytosolic innate immune sensors [28], but not following inflam-
masome activation [33,34]. MyD882/2/Trif2/2 BMDMs pro-
duced TNF-a mRNA in response to wildtype Y. pseudotuberculosis,
but not to Y. pseudotuberculosis lacking a T3SS apparatus (DyscNU)
(Table 1; Fig. 1A). This indicates that macrophages can distinguish
Yersinia expressing a T3SS from one that lacks it.
To identify the component of the T3SS apparatus recognized
by macrophages, we challenged MyD882/2/Trif2/2 BMDMs
with Y. pseudotuberculosis Dyop6 lacking all six known T3SS effector
Author Summary
Most multicellular organisms have immune sensors that
recognize molecules common among microorganisms.
Recognition of such molecules informs the host that
invading microbes are present, triggering an immune
response. Many known innate immune sensors, however,
do not appear to distinguish commensals from pathogens.
This is in spite of the fact that the host must clear
pathogens while simultaneously avoiding a response to
benign or beneficial microbes. There are few molecular
explanations for how this discrimination occurs in mam-
malian hosts. To address this problem, we analyzed the
response of mammalian cells to the gut pathogen Yersinia
pseudotuberculosis. We found that Yersinia expressing a
virulence-associated secretion system caused a transcrip-
tional response in host cells that was very different from
the response to a strain with a nonfunctional version of the
secretion system. This transcriptional response included
several distinct signaling pathways leading to production
of mediators of innate immunity, including cytokines such
as type I interferon and TNF-a. A large number of
pathogens express specialized secretion systems similar
to that in Yersinia, so these findings provide evidence that
there is a mammalian immune response to alterations in
host cells that results from pathogen attack, supporting
known systems for recognition of common microbial
molecules.
Immune Response to Yersinia Type III Secretion
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Figure 1. Extracellular Y. pseudotuberculosis expressing a functional T3SS translocator induces TLR-independent TNF-a production.
MyD882/2/Trif2/2 macrophages were infected with Y. pseudotuberculosis and tnfa mRNA levels (normalized to 18s rRNA) (A–C) and TNF-a protein
levels (D) were quantified two hours post-inoculation. (B) Phagocytosis was inhibited by pre-incubating macrophages with cytochalasin D (cytD).
The average of two to nine independent experiments 6 standard error of the mean (sem) is shown.
doi:10.1371/journal.ppat.1000686.g001
Table 1. Y. pseudotuberculosis strains used in this study.
Strain Background Mutation Reference
Wildtype IP2666 Naturally lacks full length YopT Bliska et al. 1991
Dyop6 IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ A. Davis and J. Mecsas (unpublished)
D6/DyopB IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ, DyopB This work
D6/DyopD IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ, yopDDStyI This work
DyscNU IP2666 Deletion of yscNU operon Balada-Llasat and Mecsas 2006
DyopJ IP2666 DyopJ Fisher et al. 2007
D6/pYopT IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ; pPHYopT G. Viboud and J. Bliska (unpublished)
D6/pYopTC139S IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ; pPHYopTC139S G. Viboud and J. Bliska (unpublished)
D6/DyopN IP2666 DyopH, DyopE, DyopM, DyopO, DyopJ, DyopN This work
doi:10.1371/journal.ppat.1000686.t001
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proteins. TNF-a was induced even more robustly (Fig. 1A),
indicating that these effector proteins are not required for the
macrophage response to the Yersinia T3SS. In contrast, Y.
pseudotuberculosis D6/DyopB lacking the T3SS translocator compo-
nent YopB did not induce any TNF-a in MyD882/2/Trif2/2
BMDMs (Fig. 1A). In the absence of YopB, Yersinia cannot induce
pore formation in target host cell membranes and cannot
translocate any molecules into the host cell cytosol [35,36].
However, the Y. pseudotuberculosis D6/DyopB strain does express a
T3SS needle on its surface and can secrete the translocator
component YopD under type III secretion-inducing conditions in
vitro (Fig. S1A).
Since YopB was necessary for TLR-independent recognition of
Yersinia, we reasoned that either the YopB protein itself was
recognized by macrophages or that a YopB-mediated event, such
as pore formation or translocation of an immune activating ligand
into the host cytosol, was detected by macrophages. To distinguish
between these possibilities, we assessed whether a strain of Y.
pseudotuberculosis that was incapable of type III translocation, but
still expressed YopB, could induce TLR-independent TNF-a
production. A Y. pseudotuberculosis strain that carries a frameshift
mutation in the translocator component YopD is unable to induce
pore formation or effector protein translocation into target host
cells [36], but can still secrete YopB into the culture supernatant
(Fig. S1A). Similar to the strain lacking YopB, this YopD-deficient
strain also did not induce TNF-a in the absence of TLR signaling
(Fig. S1B). This indicates that rather than direct recognition of
YopB, TLR-independent recognition of Yersinia expressing a
functional T3SS involves detection of a YopBD-mediated event.
To test whether Y. pseudotuberculosis must be internalized in order
for TLR-independent detection to occur, MyD882/2/Trif2/2
BMDMs were preincubated with the actin cytoskeletal depoly-
merizing agent cytochalasin D (cytD) to inhibit phagocytosis. This
treatment allowed 99% of the Yersinia to remain extracellular (data
not shown). However, cytD treatment did not inhibit the TNF-a
mRNA response of MyD882/2/Trif2/2 BMDMs to Yersinia
(Fig. 1B). This indicates that extracellular Yersinia expressing a
functional T3SS can trigger TLR-independent innate immune
signaling.
T3SS effector proteins modulate the TLR-independent
TNF-a response to Y. pseudotuberculosis
The T3SS effector protein YopJ has been shown to inhibit
NFkB and MAP kinase signaling, leading to dampening of TLR-
induced cytokine expression in cultured cells [18]. To determine if
TLR-independent cytokine production is also inhibited by YopJ,
we challenged MyD882/2/Trif2/2 BMDMs with Y. pseudotuber-
culosis DyopJ (Fig. 1A). This strain induced an elevated level of
TNF-a mRNA relative to the wildtype control, indicating that
YopJ interferes with TLR-independent TNF-a production.
Interestingly, Y. pseudotuberculosis Dyop6 lacking all six known
T3SS effector proteins (Dyop6) induced TNF-a mRNA to a level
three times greater than the wildtype Y. pseudotuberculosis strain, but
1.5-fold less than the DyopJ Y. pseudotuberculosis strain (p = 0.009;
Fig. 1A). Therefore, in the absence of YopJ, other translocated
effector proteins enhance the TLR-independent response to the
T3SS. In fact, the presence of a single effector Yop was sufficient
to recapitulate this stimulation. Y. pseudotuberculosis D6/pYopT
expressing only the effector protein YopT induced 1.7-fold more
TNF-a mRNA (p = 0.04; Fig. 1C) and five-fold more TNF-a
protein (p = 0.008; Fig. 1D) than the Y. pseudotuberculosis Dyop6
strain. Furthermore, Y. pseudotuberculosis D6/pYopTC139S express-
ing a catalytically inactive point mutant of YopT did not induce
this enhanced TNF-a production (Fig. 1C–D). This indicates that
while the effector protein YopJ partially inhibits TLR-independent
TNF-a production triggered by Yersinia, the catalytic activity of
YopT enhances TNF-a production.
Macrophages launch a robust transcriptional response to
T3SS translocator-positive Yersinia that includes NFkB-
and type I IFN-regulated genes
The above results indicated that there may be a global response
to the insertion of the Y. pseudotuberculosis T3SS into the host cell
membrane. To identify the spectrum of host genes regulated in
response to the Y. pseudotuberculosis T3SS, we determined the gene
expression profile of MyD882/2/Trif2/2 BMDMs after challenge
with Y. pseudotuberculosis Dyop6 expressing a functional T3SS
translocator compared to Y. pseudotuberculosis D6/DyopB expressing
a T3SS needle but defective in type III translocation (Materials
and Methods). We used strains lacking the known T3SS effector
proteins to exclude macrophage genes controlled by the catalytic
activity of these effectors. Even in the absence of the T3SS effector
proteins, we found a large number of macrophage genes
significantly regulated following challenge with Y. pseudotuberculosis
compared to the uninfected condition (Fig. S2).
The Y. pseudotuberculosis adhesin invasin has been reported to
induce host cell signaling, consistent with the fact that it engages
integrin receptors [37]. Because both the Y. pseudotuberculosis Dyop6
and D6/DyopB strains express invasin, integrin engagement may
account for at least some of the alterations in host gene expression
that are common to these two strains. Instead, we chose to focus
on host genes that were differentially regulated in response to these
two strains. Indeed, 266 genes were regulated by Y. pseudotubercu-
losis Dyop6 (compared to the uninfected condition) at least four-
fold or more than by the D6/DyopB strain (Fig. 2; Datasets S1 and
S2). These genes predominantly clustered into five groups based
on their expression pattern (cluster I–V). Most of these genes were
upregulated by the Y. pseudotuberculosis Dyop6 strain compared to
the uninfected condition, although cluster IV contains downreg-
ulated genes. Other than TNF-a, a number of cytokines,
chemokines, and costimulatory molecules were induced specifi-
cally in the presence of an intact T3SS translocator (Table 2).
Furthermore, a number of genes involved in the NFkB signaling
cascade were preferentially upregulated by Y. pseudotuberculosis
Dyop6 compared to the D6/DyopB strain (Table 3). There was a
similar pattern of expression for many of the genes controlled by
this transcription factor, as transcription was induced by two hours
post-inoculation with the Y. pseudotuberculosis Dyop6 strain and then
subsequently tapered (Fig. 3A shows three examples). This was
similar to the TNF-a expression pattern as determined by
quantitative PCR analysis (qPCR; Fig. S3). Consistent with the
panel of genes that were identified in this fashion, NFkB could
indeed be preferentially activated by Y. pseudotuberculosis Dyop6
compared to Y. pseudotuberculosis D6/DyopB, based on monitoring
infected 293T cells expressing a NFkB luciferase reporter (see
below).
A subset of genes represented in the heatmap in Fig. 2 are
known to be controlled by cytokines of the type I interferon (IFN)
family and had a distinct expression pattern. These genes were not
induced significantly until four hours post-inoculation with the Y.
pseudotuberculosis Dyop6 strain (Fig. 3B shows three examples). This
was consistent with the induction pattern of the cytokine IFN-
inducible protein of 10 kDa (IP10) that we obtained using qPCR
(Fig. S4A). In addition, most of the type I IFN-inducible genes
identified by microarray analysis fell into cluster II, where
expression was highest at four hours post-inoculation (Fig. 2;
Table 4). Consistent with induction of type I IFN-regulated genes
at later time points, mRNA levels of the gene encoding the type I
Immune Response to Yersinia Type III Secretion
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IFN family member IFNb were significantly upregulated
(p,0.0001) over uninfected levels by Y. pseudotuberculosis Dyop6
(5.4-fold60.9) compared to the D6/DyopB strain (1.2-fold60.2)
two hours post-inoculation (Fig. S4B). Similar to TNF-a, the
observed induction of IFN-b by Y. pseudotuberculosis Dyop6 did not
depend on the bacteria being internalized into macrophages
because the level of IFNb mRNA was not reduced in the presence
of cytochalasin D (data not shown).
To validate some of our microarray results, we used qPCR to
verify that a subset of the genes identified in our microarray
analysis were indeed induced by Y. pseudotuberculosis Dyop6
independently of TLRs. We infected MyD882/2/Trif2/2
BMDMs with Y. pseudotuberculosis Dyop6 or D6/DyopB and
analyzed mRNA levels of select genes two hours post-inoculation.
We found that, similar to TNF-a, genes encoding the anti-
inflammatory cytokine IL-10, the cysteine- and serine-rich nuclear
protein Axud1, and the transcription factor early growth response
protein 1 (Egr1) were transcribed by macrophages in response to
Y. pseudotuberculosis Dyop6 but not to the D6/DyopB strain (Fig. 4;
Fig. 5A). These results support those obtained from our
microarray analysis.
To determine if the presence of TLR signaling alters the
expression of genes induced in response to an intact T3SS
translocator, wildtype C57Bl/6 macrophages were challenged
with Y. pseudotuberculosis Dyop6 or D6/DyopB. In the presence of
TLR signaling, macrophages transcribed the genes encoding
TNF-a, IL-10, and Axud1 in response to both Y. pseudotuberculosis
Figure 2. Y. pseudotuberculosis expressing a functional T3SS
translocator induces robust macrophage gene expression.
MyD882/2/Trif2/2 macrophages were infected with Y. pseudotubercu-
losis Dyop6, D6/DyopB, or were left uninfected. Total RNA was isolated
and Affymetrix GeneChip Mouse Genome 430 2.0 arrays were used to
probe the relative gene expression profiles for each experimental
condition. The expression of 266 murine genes (represented by 340
probe sets) was regulated by Y. pseudotuberculosis Dyop6 at least four-
fold (p,0.05) more than by Y. pseudotuberculosis D6/DyopB during at
least one time point. The probe sets were clustered into a heat map
according to the Pearson correlation. From left to right, the 45 minute,
two hour, and four hour time points are shown for each bacterial strain.
The colorbar ranges from zero to 50-fold change in gene expression
compared to the uninfected condition where red represents upregu-
lated genes, yellow represents no change from uninfected, and blue
represents downregulated genes.
doi:10.1371/journal.ppat.1000686.g002
Table 2. Cytokine and chemokine genes induced
preferentially by Y. pseudotuberculosis expressing an intact
T3SS translocator.
Gene name1 Description Cluster
Mip1a/Ccl3 Macrophage inflammatory protein 1-alpha I
IL-15 Interleukin 15 II
IL-15Ra Interleukin 15 receptor, alpha II
Mip2/Cxcl2 Macrophage inflammatory protein 2 III
IP10/Cxcl10 IFN-inducible protein of 10 kDa III
RANTES/Ccl5 Regulated upon Activation, Normal T-cell Expressed,
and Secreted
III
TNFsf4 Tumor necrosis factor (ligand) superfamily, member 4 III
Mip1b/Ccl4 Macrophage inflammatory protein 1-beta III
KC/Cxcl1 Neutrophil-activating protein 3 V
IL-1a Interleukin 1-alpha V
IL-1b Interleukin 1-beta V
IL-10 Interleukin 10 V
Tnfsf9 Tumor necrosis factor (ligand) superfamily, member 9 V
Tnfsf14 Tumor necrosis factor (ligand) superfamily, member 14 V
MCP-1/Ccl2 Monocyte chemoattractant protein 1 V
MCP-3/Ccl7 Monocyte chemoattractant protein 3 V
Bsf3/Clcf1 B-cell stimulating factor 3 V
1Genes listed were hand-selected following literature review of genes listed in
Datasets S1 and S2, which are those that were upregulated at least 4-fold more
by Y. pseudotuberculosis Dyop6 compared to Y. pseudotuberculosis D6/DyopB
(p,0.05) according to microarray analysis.
doi:10.1371/journal.ppat.1000686.t002
Table 3. NFkB cascade genes induced preferentially by Y.
pseudotuberculosis expressing an intact T3SS translocator.
Gene name1 Description Cluster
IkBf/Nfkbiz Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, zeta
I
c-Rel Reticuloendotheliosis oncogene; NFkB subunit I
Rip2/RICK Receptor-interacting protein 2 I
Tank TRAF family member-associated NFkB activator I
Traf5 TNF receptor-associated factor 5 II
Nfkbie Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, epsilon
III
Nfkbie Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, epsilon
III
Tnfaip3/A20 Tumor necrosis factor, alpha-induced protein 3 III
Traf1 TNF receptor-associated factor 1 V
1Genes listed were hand-selected following literature review of genes listed in
Datasets S1 and S2, which are those that were upregulated at least 4-fold more
by Y. pseudotuberculosis Dyop6 than by Y. pseudotuberculosis D6/DyopB
(p,0.05) according to microarray analysis.
doi:10.1371/journal.ppat.1000686.t003
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strains (Fig. 4). This indicates that TLR ligands, such as LPS,
trigger macrophage transcription of these genes independently of
the T3SS.
TLRs antagonize induction of a subset of genes that
respond to a functional T3SS translocator
The egr1 and egr2 genes were induced preferentially by the T3SS
translocator-positive Y. pseudotuberculosis Dyop6 strain in macro-
phages lacking TLR signaling (Fig. 5A and microarray data not
shown). However, while egr1 was induced in wildtype macrophages
in response to both Y. pseudotuberculosis Dyop6 and D6/DyopB, the
mRNA levels were 11-fold lower than that induced by the Dyop6
strain in MyD882/2/Trif2/2 BMDMs. This indicates that TLR
signaling may negatively regulate egr1 expression. In order to test
this hypothesis, we tolerized wildtype macrophages to TLR ligands
by incubating them overnight with a low level of heat-killed Y.
pseudotuberculosis. This type of treatment has been used previously to
dampen subsequent TLR responses [38]. We then challenged
these tolerized macrophages with live Y. pseudotuberculosis Dyop6
and measured Egr1 mRNA levels. While untolerized wildtype
macrophages produced only low levels of Egr1 mRNA, tolerized
wildtype macrophages produced Erg1 mRNA levels similar to that
produced by MyD882/2/Trif2/2 BMDMs (Fig. 5B). Similar
results were obtained for Egr2 (data not shown). Tolerization
treatment of MyD882/2/Trif2/2 BMDMs did not affect Egr1
expression (data not shown). These data suggest that cross-talk
exists between the TLR-dependent and -independent signaling
pathways, modulating the response of a subset of genes to the
T3SS.
Figure 3. NFkB and type I IFN regulated genes exhibit different kinetic profiles following infection with T3SS translocator-positive
Y. pseudotuberculosis. (A) Three NFkB-regulated genes and (B) three type I IFN-induced genes were selected from among the 266 genes identified
by the microarray analysis described in Fig. 2. Shown is the average fold induction of the given probe set over the uninfected condition from Y.
pseudotuberculosis Dyop6-infected (diamonds) and D6/DyopB-infected (circles) BMDMs 6 sem.
doi:10.1371/journal.ppat.1000686.g003
Table 4. Type I IFN-inducible genes induced preferentially by
Y. pseudotuberculosis expressing an intact T3SS translocator.
Gene name1 Description Cluster
Irf1 Interferon regulatory factor 1 I
Ifit1/Ifi56 Interferon-induced protein with tetratricopeptide
repeats 1
II
Ifit2/Ifi54 Interferon-induced protein with tetratricopeptide
repeats 2
II
Ifit3/Ifi49 Interferon-induced protein with tetratricopeptide
repeats 3
II
Mx1 Myxovirus resistance protein 1 II
Mx2 Myxovirus resistance protein 2 II
Gbp2 Interferon-induced guanylate-binding protein 2 II
Ifi203 Interferon-inducible protein 203 II
RIG-I Retinoic acid-inducible gene 1 II
Oasl1 29–59 oligoadenylate synthetase-like 1 II
Stat2 Signal transducer and activator of transcription 2 II
IP10/Cxcl10 IFN-inducible protein of 10 kDa III
RANTES/Ccl5 Regulated upon Activation, Normal T-cell Expressed,
and Secreted
III
Ifi202b Interferon-inducible protein 203b V
1Genes listed were hand-selected following literature review of genes listed in
Datasets S1 and S2, which are those that were upregulated at least 4-fold more
by Y. pseudotuberculosis Dyop6 than by Y. pseudotuberculosis D6/DyopB
(p,0.05) according to microarray analysis.
doi:10.1371/journal.ppat.1000686.t004
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The Y. pseudotuberculosis T3SS activates NFkB
independently of the cytosolic peptidoglycan sensors
Nod1 and Nod2
The cytoplasmic innate immune sensors Nod1 and Nod2, which
are activated by peptidoglycan moieties, have been shown to
activate NFkB [6]. Rip2 is a kinase that is downstream of both
Nod1 and Nod2 and is required for induction of genes that
respond to these sensors [39,40]. We hypothesized that Nod1
and/or Nod2 could be involved in NFkB activation in response to
Yersinia infection, as peptidoglycan fragments could have access to
the host cell cytosol via the T3SS. To test this, we knocked down
expression of Nod1 and Rip2 in 293T cells using shRNAs and
monitored NFkB activation using a luciferase reporter. We found
that NFkB-driven luciferase expression in 293T cells could be
triggered by an acylated derivative of the Nod1 ligand iE-DAP
(C12-iE-DAP), which can enter the cell cytosol when added
exogenously to the cell culture (Fig. 6AB). Compared to a control
shRNA, shRNA against Nod1 (Fig. 6A) or Rip2 (Fig. 6B) caused a
clear decrease in C12-iE-DAP-induced NFkB activation. Howev-
er, knocking down either Nod1 or Rip2 did not significantly
decrease NFkB activation induced by the Y. pseudotuberculosis
Dyop6 strain. In fact, in two out of four experiments the level of
NFkB activation increased slightly upon Y. pseudotuberculosis Dyop6
infection during Rip2 knockdown compared to the LacZ shRNA
control (data not shown).
To gain further evidence that the NFkB signaling observed in
response to Y. pseudotuberculosis was independent of a peptidoglycan
activation pathway, BMDMs from MyD882/2, MyD882/2/
Rip22/2, and MyD882/2/Trif2/2 mice were analyzed. TNF-a
mRNA levels were determined after challenge of BMDMs with
Figure 4. T3SS translocator-positive and –negative Y. pseudotuberculosis can be differentiated by a TLR-independent recognition
pathway. C57Bl/6 and MyD882/2/Trif2/2 macrophages were infected with Y. pseudotuberculosis and total RNA isolated at 2 hours post-inoculation.
(A) tnfa, (B) il10, and (C) axud1 mRNA levels were quantified (normalized to 18s rRNA). Data represents average6sem from three independent
experiments.
doi:10.1371/journal.ppat.1000686.g004
Figure 5. Tolerization of TLR signaling in wildtype macrophages relieves egr1 repression during infection with Y. pseudotuberculosis.
C57Bl/6 and MyD882/2/Trif2/2 macrophages were (A) infected with Y. pseudotuberculosis and total RNA isolated at 2 hours post-inoculation or (B)
were first incubated with heat-killed Y. pseudotuberculosis overnight (tolerized) or were left untreated. The tolerized or untreated macrophages were
then infected with live Y. pseudotuberculosis Dyop6 and total RNA isolated two hours post-inoculation. Egr1 mRNA levels (normalized to 18s rRNA)
were quantified. Data represents average 6 sem from two independent experiments.
doi:10.1371/journal.ppat.1000686.g005
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either Y. pseudotuberculosis Dyop6 or D6/DyopB in order to analyze
activation of an NFkB-dependent gene in the absence of MyD88
signaling (Fig. 6C). Rip2 was dispensable for signaling downstream
of both Y. pseudotuberculosis strains, regardless of the presence or
absence of a functional T3SS translocator (Fig. 6C, MyD882/2
compared to MyD882/2/Rip22/2 cells). In fact, MyD882/2/
Rip22/2 cells produced somewhat more TNF-a mRNA in
response to either strain of Y. pseudotuberculosis compared to
MyD882/2/Rip2+/+ strains. In the case of the bacterial strain
lacking the T3SS translocator (D6/DyopB), however, TNF-a
signaling appeared to be solely TLR-dependent, as Trif was
necessary for signaling in the absence of MyD88 (Fig. 6C,
MyD882/2 compared to MyD882/2/Trif2/2 cells). In contrast,
T3SS translocator-dependent signaling occurred in BMDMs from
all the relevant mouse genotypes, regardless of intact TLR or Rip2
signaling. Therefore, we conclude that NFkB activation that
occurs in response to T3SS translocator-positive Y. pseudotuberculosis
does not involve Nod1 or Nod2 signaling.
The Y. pseudotuberculosis T3SS induces secretion of TNF-
a, but not IL-1b, independently of caspase-1
T3SS-positive strains of Yersinia have been shown to trigger
maturation and secretion of the inflammatory cytokine IL-1b in a
manner that is dependent on the host protease caspase-1 [22,41].
To determine whether caspase-1 is also involved in NFkB
signaling triggered by T3SS translocator-positive Y. pseudotubercu-
losis, we infected MyD882/2/Trif2/2 macrophages with Y.
pseudotuberculosis in the presence or absence of the caspase-1
inhibitor Z-YVAD(OMe)-FMK, and measured levels of secreted
TNF-a (Table 5). TNF-a levels remained unchanged in the
presence of caspase-1 inhibitor. This was in contrast to IL-1b
secretion, which was inhibited by Z-YVAD(OMe)-FMK by three-
fold (p,0.01). These data indicate that, as previously reported, the
Yersinia T3SS induces host caspase-1 activation and IL-1b release
[22,41]. However, the Yersinia T3SS also induces host production
and secretion of TNF-a and the signaling pathway responsible is
independent of caspase-1.
Figure 6. Y. pseudotuberculosis triggers NFkB activation independently of Nod1 and Nod2. (A–B) 293T cells were transfected with
plasmids encoding siRNA against Nod1 or EGFP (A) or Rip2 or LacZ (B) as well as a plasmid expressing an NFkB luciferase reporter gene. The
transfected cells were then infected with Y. pseudotuberculosis or treated with a synthetic Nod1 ligand, C12-iE-DAP, that is able to access the
cell cytosol. Four hours post-inoculation or post-treatment, NFkB activation was quantified by measuring luminescence. Data shown is the
average fold NFkB activation (over uninfected/untreated) 6 sem from one independent, representative experiment and each experiment was
repeated for a total of three (Nod1) to four (Rip2) replicates. * Statistically significant decrease in C12-iE-DAP-induced NFkB activation
according to the student t-Test. P,0.01 for Nod1 shRNA compared to EGFP control. P,0.03 for Rip2 shRNA compared to LacZ control. There
was no statistical difference in NFkB activation induced by Y. pseudotuberculosis Dyop6 with either Nod1 (p.0.2) or Rip2 (p.0.3) knockdown.
(C) MyD882/2, MyD882/2/Rip22/2, and MyD882/2/Trif2/2 macrophages were infected with Y. pseudotuberculosis Dyop6 or D6/DyopB and
tnfa mRNA levels (normalized to 18s rRNA) were measured two hours post-inoculation. Data shown is the average 6 sem from one
independent, representative experiment, which was repeated for a total of two replicates. * The only statistically significant decrease in tnfa
mRNA levels compared to the Trif+/+/Rip2+/+ control cells was observed for the Y. pseudotuberculosis D6/DyopB strain in Trif2/2/Rip2+/+ cells
(student t-Test, p,0.002).
doi:10.1371/journal.ppat.1000686.g006
Table 5. T3SS translocator-positive Y. pseudotuberculosis
induces TNF-a, but not IL-1b, production independently of
the inflammasome component caspase-1.
Treatment IL-1b (pg/ml) TNF-a (pg/ml)
None 1.361.5 0.860.2
Dyop61 113.067.6 1260.4671.9
Dyop6+YVAD2 37.568.33 1295.5684.3
D6/DyopB 1.560.6 6.060.8
1MyD882/2/Trif2/2 BMDMs were infected with Y. pseudotuberculosis Dyop6 or
D6/DyopB and supernatant IL-1b and TNF-a levels measured four hours post-
inoculation.
2Two hours prior to infection, the caspase-1 inhibitor Z-YVAD(OMe)-FMK was
added to the BMDMs.
3Statistically significant decrease in IL-1b concentration compared to the
Dyop6-infected, no YVAD condition (Students t-Test; p,0.01).
doi:10.1371/journal.ppat.1000686.t005
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Type III secreted products introduced into the host
cytosol independently of the T3SS apparatus do not
stimulate cytokine production
T3SS translocator-dependent cytokine induction may stem
from recognition of a YopBD pore or from introduction of innate
immune stimulating molecules into the host cytosol. To
distinguish between these two possibilities, we set up two systems
in which products secreted by Y. pseudotuberculosis via the T3SS
were introduced into the host cytosol independently of the
YopBD pore, using either scrape-loading [42] or transfection.
293T cells were chosen for scrape-loading because they form
loose adhesions to the extracellular matrix and have a high
survival rate after scrape loading (unpublished observations). To
determine the sensitivity of the 293T cell response to T3SS
translocator-positive Yersinia, we infected 293T cells with varying
numbers of live Y. pseudotuberculosis and measured induction of the
NFkB-regulated cytokine IL-8. An inoculum of as little as one Y.
pseudotuberculosis Dyop6 per five 293T cells (multiplicity of
infection, MOI = 0.2) induced IL-8 mRNA production after
two hours (Fig. 7A). In contrast, even a MOI = 20 of Y.
pseudotuberculosis D6/DyopB did not induce IL-8. These results
indicate that 293T cells produce detectable IL-8 levels in
response to a small number of Yersinia expressing a functional
T3SS translocator.
To test specifically whether molecules secreted via the Y.
pseudotuberculosis T3SS could induce cytokine production in the
absence of YopBD-mediated pore formation, we collected culture
supernatant from Y. pseudotuberculosis grown under type III
secretion-inducing conditions and introduced it into 293T cells
via scrape-loading (see Materials and Methods). Under in vitro type
III secretion-inducing conditions, Y. pseudotuberculosis strains that
express a T3SS needle apparatus secrete proteins and possibly
other molecules into the supernatant (see Fig. S1A). Scrape-
loading of culture supernatant from Y. pseudotuberculosis Dyop6,
equivalent to that produced by 50 bacteria per 293T cell, did not
result in an increase in IL-8 mRNA (Fig. 7B). In contrast, lysate
from heat-killed Y. pseudotuberculosis (HKYP), which contains
molecules such as peptidoglycan known to induce cytosolic innate
immune signaling, triggered IL-8 production when delivered
inside 293T cells via scrape loading (Fig. 7B). This was achieved
even when the equivalent of one HKYP was scrape-loaded into
one 293T cell. However, even the equivalent of 100 HKYP per
293T cell was insufficient to induce IL-8 production in the
absence of scrape-loading. Importantly, scrape-loading alone
(i.e.-nonspecific membrane disruption) did not trigger IL-8
production.
To support these results, we used transfection of primary
macrophages as a second method to deliver culture supernatants
into the host cell cytosol independently of the YopBD pore. In
order to demonstrate the sensitivity of the macrophages to T3SS
translocator-positive Y. pseudotuberculosis, we challenged macro-
phages with varying numbers of Y. pseudotuberculosis Dyop6. A
MOI = 0.1 (for TNF-a) or a MOI = 1.0 (for IFNb) induced
detectable cytokine mRNA levels (Fig. S5A,D). To test specifically
whether molecules secreted by the T3SS could induce cytokine
production in the absence of YopBD-mediated pore formation, we
transfected MyD882/2/Trif2/2 macrophages with supernatants
from bacterial cultures grown under type III secretion-inducing
conditions. Neither TNF-a nor IFNb was detected even after
transfection with supernatant equivalent to about 70 Y. pseudotu-
berculosis per macrophage (Fig. S5B,E). In contrast, transfection of
small amounts of HKYP lysate into macrophages elicited both a
significant TNF-a and IFNb response (Fig. S5C,F).
Collectively, these data indicate that neither introduction of Y.
pseudotuberculosis type III secreted products into the cytosol of
mammalian cells independently of the YopBD pore nor
nonspecific membrane disruption can recapitulate induction of
NFkB-regulated cytokines or type I IFN triggered by Y.
pseudotuberculosis expressing a functional T3SS translocator.
Figure 7. Neither introduction of type III secreted molecules into the cytosol of 293T cells nor nonspecific membrane disruption
induce IL-8 production. (A) 293T cells were infected with different MOIs of live Y. pseudotuberculosis for two hours. (B) Filtrate from Y.
pseudotuberculosis Dyop6 or DyscNU culture grown under type III secretion-inducing conditions was scrape-loaded into 293T cells for 5–10 minutes
and the scrape-loaded cells incubated for an additional two hours. The DyscNU strain does not express a T3SS, does not secrete any T3SS cargo into
the culture supernatant, and is the negative control for scrape-loading Dyop6 culture filtrate. Alternatively, varying amounts of heat-killed and lysed
Y. pseudotuberculosis or buffer were scrape-loaded into 293T cells for 5–10 minutes and the scrape-loaded cells incubated for an additional two
hours. Total RNA was isolated and il8 mRNA levels (normalized to 18s rRNA) were quantified. Data shown is the average6sem from one independent,
representative experiment and each experiment was repeated for a total of two (A) to three (B) replicates. * Statistically significant increase
(p,0.0001) in il8 levels according to the student t-Test compared to uninfected (A) or scrape only (B) controls.
doi:10.1371/journal.ppat.1000686.g007
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Discussion
We have characterized a previously unknown mammalian
innate immune response to the enteropathogen Y. pseudotuberculosis.
Unlike TLR recognition of Yersinia, the TLR-, Nod1/2-, and
caspase-1-independent pathway described here is able to distin-
guish between Y. pseudotuberculosis expressing a functional T3SS
and Y. pseudotuberculosis lacking this essential virulence determinant.
Because the ensuing immune response includes at least two distinct
signaling branches with different expression profiles, we propose
the involvement of multiple cytosolic immune sensors. Bacterial
uptake into host cells was not required for T3SS-stimulated NFkB
activation or type I IFN production, indicating that extracellular
Yersinia capable of type III translocation can activate diverse
cytosolic innate immune signaling pathways. Although the host
response that is detailed here does not require the presence of
known T3SS effectors, cytokine production triggered by these
recognition events is modulated in opposing directions by at least
two such effector proteins, YopJ and YopT. Collectively, these
results suggest multiple layers of host manipulation carried out by
the Y. pseudotuberculosis T3SS.
Dozens of animal and plant pathogens use specialized secretion
systems to deliver bacterial proteins into the cytosol of target host
cells in order to manipulate host functions and promote virulence
[9,43]. We have shown here that the mammalian innate immune
system possesses the ability to specifically recognize and respond to
pathogenic Y. pseudotuberculosis based on bacterial utilization of one
such virulence-associated secretion system. We hypothesize that
different features of the Y. pseudotuberculosis secretion system are
recognized by distinct cytosolic innate immune receptors,
launching a unique immune response.
Inflammasome complexes, which contain such cytosolic sensors,
are involved in caspase-1 activation, facilitating release of the
cytokines IL-18 and IL-1b in response to Y. pseudotuberculosis, Y.
pestis, Pseudomonas aeruginosa, Salmonella typhimurium, Legionella pneu-
mophila, and Burkholderia pseudomallei that express functional T3/
4SSs [22,44–52]. Many of these inflammasome activation events
also require bacterial flagellin, suggesting that flagellin is delivered
into the cytosol of target host cells through these specialized
secretion systems [53], triggering an immune response. While Y.
pestis encodes an inactive flhD allele that results in lack of flagellin
expression, T3SS-competent Y. pestis still activates caspase-1 [22],
perhaps because the pore-forming ability of the Yersinia T3SS is
sufficient to stimulate inflammasome activity. Such a mechanism
of stimulation would be similar to the response of inflammasome
complexes to a diverse set of pore-forming toxins [25].
Interestingly, when the inactive, Y. pestis allele of flhD is crossed
into the Y. pseudotuberculosis Dyop6 background, TNF-a is still
induced in a TLR-independent manner (data not shown). This
suggests that NFkB activation triggered by the Yersinia T3SS is also
independent of flagellin. Furthermore, we could find no role for
the inflammasome-associated cytosolic sensor Nalp3 in Y.
pseudotuberculosis-induced TNF-a production. In addition, the
potassium ionophore nigericin, which induces IL-1b secretion
via the Nalp3 inflammasome, did not promote TNF-a production
(data not shown). Lastly, we found that NFkB induced by T3SS-
positive Y. pseudotuberculosis is independent of caspase-1, ruling out a
role for caspase-1-inflammasome complexes in this pathway
(Table 5).
Y. pseudotuberculosis was previously shown to induce production of
the NFkB-regulated chemokine IL-8 in HeLa cells and this was
dependent on YopB expression [29]. Here we show that in
addition to stimulation of IL-8 production in 293T cells (Fig. 7)
and HeLa cells [29], T3SS-competent Y. pseudotuberculosis triggers a
large-scale transcriptional response in mouse macrophages. This
represents a much broader response to a T3SS than previously
appreciated. Interestingly, T3SS-competent Citrobacter rodentium has
been shown to induce IL-8 and TNF-a production in HT29
human intestinal epithelial cells dependent on the peptidoglycan
sensors Nod1 and Nod2, respectively [28]. We also observed Y.
pseudotuberculosis-induced IL-8 production in HT29 cells dependent
on an intact T3SS (data not shown). However, we did not find a
role for Nod1 or Nod2 in T3SS-dependent NFkB activation in our
293T cell reporter system or in primary macrophages (Fig. 6).
Similarly, T3SS-competent B. pseudomallei triggers IL-8 production
in 293T cells and this response is also independent of Nod1 [54].
The nature of the putative ligand(s) that triggers NFkB-dependent
cytokine production by T3SS-competent Y. pseudotuberculosis and B.
pseudomallei remains to be determined. Intriguingly, induction of
IL-8 by B. pseudomallei does not occur in the absence of a functional
T3SS even though this bacterium is able to access the host cytosol
[54,55]. This indicates that the presence of a bacterium in the host
cell cytosol does not necessarily lead to immune detection. Rather,
it is the active process of type III translocation into host cells that
allows recognition to occur.
In contrast to innate immune ligands such as peptidoglycan,
microbially-derived nucleic acids induce a distinct mammalian
immune response that includes type I IFN family members [56].
Expression of these cytokines involves not only NFkB, but also the
transcription factor IRF3 [57]. Following production and secretion
of type I IFNs, the type I IFN receptor becomes activated in a
paracrine and autocrine manner. This leads to the upregulation of
a number of type I IFN-responsive genes, such as the chemokine
IP10. Both cytosolic RNA and DNA can induce this type of
amplified type I IFN response [56,58]. Specific RNA moieties are
recognized by two sensors, Mda5 and RIG-I, that reside in the
mammalian cytosol [59]. However, the identity of the cytosolic
DNA sensors remain unclear. The protein DAI/DLM-1/ZBP1
has shown to be involved in upregulation of type I IFN in response
to DNA in some cell types but not in others [60–62], suggesting
possible redundancy with other, as yet unidentified receptors.
Indeed, several cell types from DAI2/2 mice still responded to
cytosolic DNA by producing type I IFN [63]. Another cytosolic
DNA receptor, AIM2, has been described that induces NFkB and
caspase-1 activation, but not type I IFN [64–67]. While at least
some DNA detection pathways are independent of the RNA
sensors RIG-I and Mda5, another pathway exists that depends on
RNA polymerase III-mediated transcription of cytosolic DNA
templates, leading to synthesis of RNA intermediates that trigger
RIG-I-dependent type I IFN production [68,69]. Interestingly,
over 60% of the genes induced by introducing DNA into mouse
embryonic fibroblasts [70] were also regulated by T3SS
translocator-positive Yersinia in MyD882/2/Trif2/2 macrophages
(data not shown). It is tempting to speculate that nucleic acids may
enter the host cell cytosol during Y. pseudotuberculosis type III
translocation, triggering a type I IFN response.
The T4SSs of two other pathogens, Brucella abortus and L.
pneumophila, have been implicated in induction of type I IFNs
[71,72]. Because T4SSs are evolutionarily related to conjugation
machinery, it is feasible that DNA is translocated into the target
host cell, activating a cytosolic innate immune sensor. However,
the nature of the Y. pseudotuberculosis type I IFN-inducing ligand is
unclear, as no evidence exists that nucleic acids are secreted or
translocated through a T3SS. Interestingly, we found that adding
exogenous, synthetic RNA to MyD882/2/Trif2/2 macrophages
infected with Y. pseudotuberculosis led to an enhanced IFNb response
(Fig. S6). Importantly, this was dependent on the bacteria
expressing a functional T3SS translocator, indicating that
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extracellular nucleic acids can leak into the cytosol of mammalian
cells during the process of type III translocation.
While an extracellular pathogen, group B streptococcus, was
recently shown to trigger type I IFN production in a TLR-
independent manner, bacterial phagocytosis and phagosomal
membrane disruption were required [73]. To our knowledge,
the Yersinia T3SS-dependent induction of a type I IFN response
shown here is the first demonstration of an extracellular pathogen
inducing TLR-independent type I IFN in the absence of bacterial
internalization into host cells. This indicates that Y. pseudotubercu-
losis may employ a novel mechanism of innate immune activation.
Whether type I IFN induction by the T3SS hinders or aids Y.
pseudotuberculosis survival in vivo remains to be determined since the
type I IFN receptor has been shown to facilitate or inhibit bacterial
growth in mice depending on the type of pathogen used [74–78].
It will be important to determine the contribution of T3SS-
induced type I IFN signaling to survival of mice during infection
with Yersinia.
Previous work has shown that the Yersinia T3SS effector protein
YopJ inhibits the NFkB, MAP kinase, and IRF3 signaling
pathways in target host cells [79]. Consistent with these data, we
observed reduced TNF-a levels triggered by Y. pseudotuberculosis
expressing YopJ. Surprisingly, we also found that Y. pseudotubercu-
losis expressing either the T3SS effector protein YopT (Fig. 1) or
YopE (data not shown) induced elevated TNF-a levels. This was
dependent on the catalytic activity of these proteins because YopT
and YopE point mutants that lack a catalytically active residue did
not trigger these enhanced TNF-a levels (Fig. 1 and data not
shown). YopT is a cysteine protease that cleaves the prenyl group
of RhoGTPases, mislocalizing them from the plasma membrane
[80]. YopE is a Rho GTPase activating protein (GAP) that
accelerates the hydrolysis of GTP on RhoGTPases [17]. Both
YopT and YopE lead to a loss of activated RhoGTPases from the
plasma membrane and to actin cytoskeletal rearrangements.
Interestingly, the RhoGTPase Rac1 was recently shown to
negatively regulate Nod2 signaling, possibly by altering its
subcellular localization [81,82]. In addition, proteins that
modulate the actin cytoskeleton have been linked to Nod1-
dependent activation of NFkB [83]. While we could not find a role
for Nod1 or Nod2 in Yersinia-induced NFkB activation (Fig. 6), it is
possible that RhoGTPases may affect the activity of other cytosolic
innate immune sensors.
Based on the data presented here, we propose that extracellular
Y. pseudotuberculosis activates the cytosolic innate immune system
during the process of type III translocation in a manner that is
dependent on both YopBD-mediated pore formation as well as
entrance of innate immune activating molecules into the target
host cell cytosol (Fig. 8). The ability of extracellular Yersinia to
trigger this response indicates that phagosomal degradation of the
bacteria is not required to release the active ligands. In addition,
the diverse transcriptional response to T3SS translocator-positive
Yersinia in the absence of TLR signaling points to involvement of
cytosolic innate immune sensors since no other known surface-
associated proteins are capable of inducing such a robust, de novo
response [84–86]. If the putative receptor(s) recognizing T3SS-
competent Yersinia are not surface-associated, then the active
components must penetrate the host cell to trigger the observed
signaling. It is possible that the Yersinia T3SS induces the opening
of a surface channel that allows an immune activating ligand to
enter the cytosol. Alternatively, YopBD-mediated pore formation
may allow molecules other than T3SS effector proteins inside
target host cells. A possible model is that more than one such
molecule enters the host cell, explaining the varied nature of the
innate immune response. However, it is possible that one molecule
is responsible for initiating the entire response and that its cognate
receptor is capable of triggering several different signaling
pathways with distinct kinetics. We could not recapitulate the
signaling triggered by T3SS-competent Yersinia by introducing
type III secreted molecules into host cells independently of the
T3SS nor by inducing nonspecific membrane disruption. It is
possible that the immune activating ligands are not secreted via the
Yersinia T3SS during growth in bacterial culture media, but are
translocated into host cells. Alternatively, the act of translocation
(YopBD-mediated entry of activating ligands) may be specifically
required. The nature of these putative ligands remains unclear, as
we did not find a role for peptidoglycan or flagellin in innate
immune recognition of the Yersinia T3SS.
The data presented here describing induction of inflammatory
cytokines in response to T3SS translocator-positive Y. pseudotuber-
culosis is consistent with the well-established ability of enteropatho-
genic Yersinia to cause acute, localized gut inflammation [10]. Our
results demonstrating cross-talk between TLR signaling and
T3SS-dependent cytosolic signaling in response to Yersinia (Fig. 5)
indicate that both pathways contribute to the overall immune
response observed during Yersinia infection. Furthermore, in cells
that are normally unresponsive to some TLR ligands (such as
intestinal epithelial cells), recognition of a functional T3SS may
play a primary role in specifically recognizing pathogenic bacteria.
It will be important to determine the specific contribution of TLR-
independent recognition of Yersinia in terms of both virulence of
the pathogen as well as the intestinal inflammation caused by
infection.
Figure 8. Activation of cytosolic innate immune signaling by
the Y. pseudotuberculosis T3SS requires a YopBD-mediated
translocation event. Y. pseudotuberculosis expressing a functional
T3SS translocator triggers NFkB and type I IFN innate immune signaling
independently of T3SS effector proteins. This response requires the
pore-forming proteins YopBD and cannot be recapitulated by
nonspecific membrane disruption nor by introducing Y. pseudotuber-
culosis T3SS secreted molecules into host cells independently of the
YopBD pore. We propose that both (1) YopBD-mediated membrane
insertion or pore formation and (2) cytosolic entry of multiple immune
activating molecules capable of triggering different transcriptional
events are required for full activation of the innate immune response to
the Y. pseudotuberculosis T3SS.
doi:10.1371/journal.ppat.1000686.g008
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Materials and Methods
All animal use procedures were in strict accordance with the
NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Tufts University Institutional Animal Care and
Use Committee.
Bacterial strains
The Y. pseudotuberculosis strains used in this study (Table 1) were
derived from the serogroup III strain IP2666pIB1 (Bliska et al.
PNAS 1991). The Dyop6 and D6/DyopB strains were constructed
using the suicide plasmids described by Logsdon and Mecsas [87].
The D6/DyopN strain was constructed using the suicide plasmid
described by Davis and Mecsas [88]. The D6/pYopT and D6/
pYopTC139S strains were constructed by electroporating
pPHYopT and mating pPHYopTC139S, kind gifts from Dr.
James Bliska, into the Dyop6 strain. These plasmids express
wildtype YopT or YopT carrying a substitution mutation in a
catalytically active residue under the control of the YopH
promoter. The D6/pYopT strain was able to cause rounding of
macrophages (indicative of Yop intoxication) and caused the entry
of Rac1 into the nucleus of Cos1 cells (data not shown), while the
D6/pYopTC139S strain did not. The D6/yopDDstyI strain was
constructed by mating pSB890 encoding the yopDDstyI allele, a
kind gift from Dr. Tessa Bergsbaken and Dr. Brad Cookson, into
the Dyop6 strain. The yopDDstyI allele was constructed according
to the strategy described by Viboud et al. [29] and harbors a
frameshift mutation in yopD. Y. pseudotuberculosis strains were grown
in 26 YT overnight at 26uC with agitation for incubation with
macrophages or 293T cells. The overnight cultures were diluted
into 26 YT containing 20 mM sodium oxalate and 20 mM
MgCl2 (low calcium medium) in order to obtain an OD600 of 0.2.
These back-diluted cultures were grown at 26uC for 1.5 h with
agitation, and transferred to 37uC for an additional 1.5 h with
agitation to induce the expression of the type III secretion system
[89]. In order to make culture fitrates for scrape-loading, the low
calcium cultures were filtered through a 0.22 mm syringe filter
(Millipore). The filtrate was then either left at its original
concentration or was concentrated two-fold in a speed-vac
centrifuge.
Mice
MyD882/2/Trif2/2 mice were a gift from Dr. Shizuo Akira.
C57Bl/6 mice were purchased from Jackson Laboratories.
MyD882/2 [90] and Rip22/2 [39] mice have been described.
Primary macrophages and cell lines
Bone marrow derived macrophages (BMDMs) were obtained as
previously described [74], except engineered NIH-3T3 cells were
used as a source of CSF [38]. The harvested macrophages were
frozen and stored in liquid nitrogen. Frozen aliquots were thawed
and plated one day prior to use in Dulbecco’s modified Eagle
medium (Gibco) supplemented with 10% fetal bovine serum
(HyClone) and L-glutamine (Gibco). 293T cells were passaged and
plated in the identical medium.
Macrophage infections
BMDMs were plated onto six-well plates (Falcon) at a density of
106 cells per ml and incubated at 37u with 5% CO2 overnight.
One day later, the cells were inoculated with approximately
1–36107 Y. pseudotuberculosis grown under type III secretion-
inducing conditions (see Bacterial Strains section above) for a
multiplicity of infection (MOI) of approximately 10:1 (unless
otherwise specified). The bacteria were then allowed to settle onto
the macrophage monolayer for 30 minutes at 37u with 5% CO2.
This treatment allowed approximately two-thirds of the macro-
phages to be associated with one or two bacteria thirty minutes
post-inoculation (data not shown). The media was then filtered
through a 0.22 mm syringe filter (Millipore). This was done in
order to remove any non-attached or non-internalized bacteria
without removing any cytokines secreted by the macrophages
during the initial 30 minutes of incubation. This treatment
prevented the macrophage monolayer from becoming over-
whelmed with bacteria by the end of the inoculation period and
yet allowed any extracellular bacteria attached to macrophages
and in the process of type III secretion to remain viable. Two
hours post-inoculation, macrophage supernatants were collected
and stored at 280uC. Macrophage monolayers were then washed
once with phosphate-buffered saline and total RNA was harvested
using the RNAqueous kit (Ambion) according to the manufactur-
er’s instructions. For inhibition of phagocytosis, BMDMs were
treated with 2 mM cytochalasin D (Sigma) 30 minutes prior to
infection.
Quantitative PCR
The DNA-free kit (Ambion) was used to remove any
contaminating genomic DNA from the total RNA samples
harvested as described above. Total RNA yield was calculated
using a NanoDrop ND-1000 spectrophotometer (Thermo Scien-
tific) and 2 mg RNA was used to make cDNA as previously
described [74]. SYBR Green PCR master mix (Applied Biosys-
tems) was used for qPCR reactions according to the manufactur-
er’s instructions using a Mx3005P (Stratagene) or DNA Engine
Opticon 2 (BioRad) qPCR machine and a 60uC annealing
temperature. The results were analyzed using the Mx3005P or
Opticon 2 software. QPCR primers used in this study are
described in Table S1. All qPCR primers were validated in
silico using NCBI mapviewer (www.ncbi.nlm.nih.gov/projects/
mapview/).
TCA precipitation
Y. pseudotuberculosis was grown under type III secretion inducing
conditions as described in the Bacterial Strains section above,
except the cultures were incubated at 37uC for an additional
30 minutes (two hours total). The cultures were plated on LB
plates to determine CFU/ml. 900 ml of culture was pelleted and
800 ml supernatant was removed. Trichloroacetic acid was added
to the supernatant for a final concentration of 10% and the
mixture was incubated on ice for 15 minutes. The mixture was
pelleted for 15 minutes at 13,000 rpm and the pellet was washed
with acetone. The washed pellet was resuspended in 50 ml
Laemmli buffer and frozen at 280uC. The samples were thawed
and boiled for five minutes. Approximately half of each sample
(the samples were normalized for CFU/ml) was run on a 12.5%
polyacrylamide gel and the protein bands visualized with
coomassie blue staining.
Microarray
MyD882/2/Trif/2/2 BMDMs were infected as described
above with Y. pseudotuberculosis Dyop6 or D6/DyopB or were left
uninfected. After 45 minutes, two hours, or four hours post-
inoculation, total RNA was harvested as described above except
that two wells of macrophages were pooled per condition to yield
enough RNA for microarray analysis. The infection was then
repeated on a separate day to yield two biological replicates per
condition. 5 mg total RNA was used to make probes for GeneChip
Mouse Genome 430 2.0 arrays using the One-Cycle cDNA
synthesis protocol and array hybridization was performed
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according to the manufacturer’s instructions (Affymetrix). A
GeneChip Fluidics Station was used to wash the arrays and a
GeneChip Scanner was used to read the arrays (Affymetrix).
GeneChip Operating Software was used to analyze the quality of
the hybridizations (Affymetrix). GeneSpring GX software (Agilent)
was used to analyze the microarray data and the GC Robust
Multiarray Averaging method was used for data normalization.
Heat-killed Y. pseudotuberculosis
To make heat-killed Y. pseudotuberculosis, the wildtype IP2666
strain was grown overnight at 26u with agitation in Luria-Bertani
broth. The overnight culture was heat-killed at 60uC for one hour,
aliquoted, and frozen at 280uC in the absence of glycerol.
Aliquots were thawed at room temperature before use. Very few
intact bacteria could be visualized by microscopy (unpublished
observations), indicating lysis occurred upon freeze/thawing. The
culture was plated before and after heat-killing to calculate the live
colony forming unit (CFU) equivalents in the heat-killed mixture
and to ensure complete killing.
Tolerization of TLR signaling
C57Bl/6 BMDMs were plated onto six-well plates (Falcon) at a
density of 26106 per well in 2 ml of media containing 26105 heat-
killed Y. pseudotuberculosis. The cells were incubated overnight at 37u
with 5% CO2. The next day, the tolerized macrophages were
inoculated with live Y. pseudotuberculosis or left uninfected as
described in the Macrophage infections section above.
Nod1 and Rip2 knockdown
293T cells were plated at a density of 2.56104 per 100 ml in 96
well plates (Corning). One day later, the cells were transfected with
400 ng per well of plasmid encoding shRNA specific for Nod1, Rip2
or control shRNA (EGFP for Nod1 and LacZ for Rip2) using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. The Nod1 and EGFP shRNA constructs were cloned
into the pRNAT-U6.1/Neo vector backbone (GenScript). The
Nod1 shRNA construct #1 and shRNA EGFP control were based
on previously published siRNA sequences (Viala et al. 2004). The
Nod1 shRNA construct #2 (59- GATCCCGTCAAAGGCAG-
CACGGAAGTGCTTGATATCCGGCACTTCCGTGCTGCC-
TTTGATTTTTTCCAAA -39) was designed using GenScript
siRNA Design Center (V. Losick and R. Isberg). The Rip2 and
LacZ shRNA plasmids were purchased from InvivoGen. 200 ng per
well of an NFkB luciferase reporter plasmid (Stratagene) was
transfected into 293T cells either simultaneously with the Nod1 or
EGFP shRNA plasmids or 24 hours after the Rip2 or LacZ shRNA
plasmids. After 48 hours of shRNA plasmid transfection, the 293T
cells were infected with 3–46105 Y. pseudotuberculosis Dyop6 or D6/
DyopB per well. Since the 293T cells doubled at least twice during the
48 hour transfection period, the MOI was approximately 3:1.
Alternatively, transfected 293T cells were treated with 1 mg/ml C12-
iE-DAP, an acylated derivative of the iE-DAP Nod1 ligand that is
able to enter the cytosol of cultured cells (InvivoGen). After four
hours of infection with Y. pseudotuberculosis or treatment with C12-iE-
DAP, luminescence was measured using the SteadyLite Plus reporter
gene assay system (PerkinElmer) and a SpectraMax M5 microplate
reader (Molecular Devices).
Caspase-1 inhibition
BMDMs were plated onto 24 well plates (Falcon) at a
concentration of 5.756105 per ml and incubated overnight. The
irreversible caspase-1 inhibitor Z-YVAD(OMe)-FMK (Santa Cruz
Biotechnology) was added at a concentration of 20 mM two hours
prior to infection. The cells were inoculated with approximately
1–46107 Y. pseudotuberculosis grown under type III secretion-
inducing conditions (see Bacterial Strains section above) for a
multiplicity of infection (MOI) of approximately 20:1. Four hours
post-inoculation, supernatants were collected and frozen at
280uC.
TNF-a and IL-1b protein detection
For Fig. 1D, the amount of TNF-a protein in supernatants of
infected macrophages was measured as described in Auerbuch
et al. [74] using the Cytometric Bead Array Mouse Inflammation
Kit (BD Biosciences). For Table 5, frozen supernatants were
centrifuged at 13,000 rpm for 1 min and TNF-a and IL-1b
protein levels were measured using a plate-based ELISA
(eBioscience) and a Victor 3 microplate reader (PerkinElmer).
Scrape-loading
The scrape-loading protocol used was adapted from McNeil
et al. [42]. 293T cells were plated at a density of 0.5–16106 cells
per ml in six well plates. One day later, the cells were washed once
with warm HBSS. 300 ml warm HBSS plus ligand were added to
each well. MOI equivalents of 0.1–100 HKYP or 150 ml of
culture filtrate from live Y. pseudotuberculosis grown under type III
secretion-inducing conditions (see Bacterial Strains section above)
were used as ligands. Cell monolayers were then scraped with a
cell scraper and incubated at 37uC for five to ten minutes. The
cells were then washed off the plastic with 5 ml of warm HBSS
and pelleted. The cells were resuspended in 2 ml warm media,
plated on fresh six well plates, and incubated at 37uC for two
hours. Alternatively, 293T cells were incubated with HKYP
(MOI 100) in the absence of scraping for two hours as a negative
control. Total RNA was then harvested as described for infected
macrophage monolayers and IL-8 mRNA levels measured by
qPCR as described above.
293T cell infections
293T cells were plated at a density of 56105 cells per ml in six
well plates. One day later, the cells were inoculated with Y.
pseudotuberculosis grown under type III secretion-inducing condi-
tions at a MOI of 1:10 to 10:1 (Yersinia:293Ts). The monolayer
supernatants were filtered after 30 minutes as described for
macrophage infections. IL-8 mRNA was measured after two
hours of total infection as described above.
Macrophage transfection
Primary macrophages were plated onto six well plates at a
concentration of 106 per ml. One day later, MOI equivalents of
0.1–10 HKYP or 250 ml per well of culture filtrate from live Y.
pseudotuberculosis grown under type III secretion-inducing condi-
tions were transfected into the macrophages using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s recommenda-
tions (5 ml Lipofectamine 2000 reagent per well). The cells were
then incubated for two hours. Total RNA was harvested and tnfa
or ifnb mRNA levels measured as described above. The culture
fitrates did not inhibit the transfection process because transfection
of both the synthetic RNA poly(I:C) and culture filtrate together
into macrophages did not lead to reduced ifnb mRNA levels
compared to poly(I:C) alone (data not shown).
Supporting Information
Table S1 Quantitative PCR primers used in this study.
Found at: doi:10.1371/journal.ppat.1000686.s001 (0.03 MB
DOC)
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Figure S1 Y. pseudotuberculosis lacking YopD expression secretes
YopB but does not induce TLR-independent TNF-a production.
(A) Supernatants from Y. pseudotuberculosis cultures grown under
type III secretion-inducing conditions were subject to TCA
precipitation, run on a polyacrylamide gel, and stained with
coomassie blue. (B) MyD882/2/Trif2/2 macrophages were
infected with Y. pseudotuberculosis and tnfa mRNA levels (normalized
to 18s rRNA) were quantified two hours post-inoculation.
Found at: doi:10.1371/journal.ppat.1000686.s002 (9.69 MB TIF)
Figure S2 Y. pseudotuberculosis expressing a functional T3SS
translocator regulates a greater number of macrophage genes than
translocator-negative Y. pseudotuberculosis. MyD882/2/Trif2/2
macrophages were infected with Y. pseudotuberculosis Dyop6 or
Dyop6/DyopB or were left uninfected. Total RNA was isolated
45 minutes, two hours, or four hours post-inoculation and
Affymetrix GeneChip Mouse Genome 430 2.0 arrays were used
to probe the relative gene expression profiles for each experimen-
tal condition. Probe sets regulated by either Y. pseudotuberculosis
Dyop6 (diamonds) or Y. pseudotuberculosis Dyop6/DyopB (x) at least
two-fold over the uninfected condition (p,0.1) were selected.
Shown are the log10 of the fold-change values of these selected
probe sets. Positive values indicate up-regulation and negative
values indicate down-regulation compared to the uninfected
condition. For the 45 minute time point, N = 280 (Dyop6) and
N = 263 (Dyop6/DyopB). For the two hour time point, N = 1248
(Dyop6) and N = 232 (Dyop6/DyopB). For the four hour time
point, N = 2215 (Dyop6) and N = 338 (Dyop6/DyopB).
Found at: doi:10.1371/journal.ppat.1000686.s003 (0.17 MB PDF)
Figure S3 Tnfa mRNA levels peak two hours after inoculation
with translocator-positive Y. pseudotuberculosis. MyD882/2/Trif2/2
macrophages were infected with Y. pseudotuberculosis Dyop6
(diamonds) or Dyop6/DyopB (circles) and total RNA isolated at
2 hours, 4 hours, or 6 hours post-inoculation. Average tnfa mRNA
levels (normalized to 18s rRNA) are shown.
Found at: doi:10.1371/journal.ppat.1000686.s004 (0.10 MB PDF)
Figure S4 Ifnb mRNA and type I IFN-regulated gene expression
are preferentially induced by T3SS translocator-positive Y.
pseudotuberculosis. MyD882/2/Trif2/2 macrophages were infected
with Y. pseudotuberculosis Dyop6 (diamonds) or Dyop6/DyopB
(circles) and total RNA isolated at 2 hours (A and B), 4 hours,
or 6 hours (A) post-inoculation and qPCR analysis performed.
Average ip10 (A) and ifnb (B) mRNA levels (normalized to 18s
rRNA) are shown 6 sem.
Found at: doi:10.1371/journal.ppat.1000686.s005 (0.11 MB PDF)
Figure S5 Transfection of type III secreted molecules into
primary macrophages does not induce TNF-a or IFNb. (A,D)
MyD882/2/Trif2/2 macrophages were infected with varying
amounts of live Y. pseudotuberculosis for two hours. Filtrates from
cultures of Y. pseudotuberculosis grown under type III secretion-
inducing conditions (B,E) or HKYP (C,F) were transfected into
MyD882/2/Trif2/2 macrophages and incubated for two hours.
Total RNA was isolated and tnfa (A–C) and ifnb (D–F) mRNA levels
(normalized to 18s rRNA) were quantified. Data shown
is the average 6 sem from one independent, representative
experiment and each experiment was repeated for a total of two
replicates. * Statistically significant increase (p,0.0001) in cytokine
mRNA levels according to the student t-Test compared to
uninfected (A) or lipofectamine only (C,F) controls. ** p = 0.0001.
*** p,0.0005. Y. pseudotuberculosis strains lacking the regulatory
protein YopN hypersecrete Yops [86] and the D6/DyopN strain was
included to test whether T3SS cargo from a hypersecreting Y.
pseudotuberculosis strain could trigger IL-8 production.
Found at: doi:10.1371/journal.ppat.1000686.s006 (0.15 MB PDF)
Figure S6 Exogenously-added, synthetic RNA synergizes with
yopB-expressing, but not yopB-deficient, Y. pseudotuberculosis to induce
IFNb mRNA expression. MyD882/2/Trif2/2 macrophages were
infected with Y. pseudotuberculosis Dyop6, Dyop6/DyopB, or DyopJ in
the presence or absence of 1mg/ml poly(I:C). Total RNA was
isolated at 2 hours post-inoculation and qPCR analysis performed.
Data shown is the average ifnb mRNA level (normalized to 18s
rRNA)6sem from one independent, representative experiment and
the experiment was repeated for a total of three replicates.
Found at: doi:10.1371/journal.ppat.1000686.s007 (0.10 MB PDF)
Dataset S1 Identity of genes regulated by Y. pseudotuberculosis
Dyop6 at least four-fold (p,0.05) more than by Y. pseudotuberculosis
Dyop6/DyopB. Fold-change compared to the uninfected condition
and the p value for each probe set is shown.
Found at: doi:10.1371/journal.ppat.1000686.s008 (0.11 MB XLS)
Dataset S2 Identity of genes found in clusters I–V shown in the
heatmap in Figure 2A.
Found at: doi:10.1371/journal.ppat.1000686.s009 (0.11 MB XLS)
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